What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? by Cuthbertson, D et al.
 1 
What have human experimental overfeeding studies taught us  1 
about adipose tissue expansion and susceptibility to obesity and metabolic 2 
complications? 3 
Daniel J Cuthbertson
1,2
, Tom Steele
1
, John P Wilding
1,2
, Jason CG Halford
3
, Jo A 4 
Harrold
3
, Mark Hamer
4
, Fredrik Karpe
5
.  5 
 6 
1
Obesity and Endocrinology Research Group, University Hospital Aintree, UK, 7 
2
Institute of Ageing and Chronic Disease, University of Liverpool 8 
3
Psychological Sciences, Eleanor Rathbone Building, University of Liverpool, 9 
Liverpool, L69 7ZA, UK 10 
4
National Centre for Sport & Exercise Medicine, Loughborough University 11 
5
Oxford Centre for Diabetes, Endocrinology & Metabolism 12 
 13 
Running title: Overfeeding, adipose expansion and metabolic risk 14 
 15 
 16 
Correspondence: 17 
Dr. Daniel Cuthbertson 18 
Obesity and Endocrinology Research Group,  19 
University Hospital Aintree, 20 
Lower Lane, Liverpool L9 7AL 21 
Tel: +44 (0) 151 529 5911 22 
Fax: +44 (0) 151 529 5888 23 
E-mail: daniel.cuthbertson@liverpool.ac.uk 24 
 25 
 2 
Abstract 1 
Overfeeding experiments, in which we impose short-term positive energy balance, 2 
help unravel the cellular, physiological and behavioural adaptations to nutrient excess. 3 
These studies mimic longer-term mismatched energy expenditure and intake. There is 4 
considerable inter-individual heterogeneity in the magnitude of weight gain when 5 
exposed to similar relative caloric excess reflecting variable activation of 6 
compensatory adaptive mechanisms. Significantly, given similar relative weight gain, 7 
individuals maybe protected from/predisposed to metabolic complications (insulin 8 
resistance, dyslipidaemia, hypertension), non-alcoholic fatty liver disease and 9 
cardiovascular disease. Similar mechanistic considerations underpinning the 10 
heterogeneity of overfeeding responses are pertinent in understanding emerging 11 
metabolic phenotypes e.g. metabolically unhealthy normal weight and metabolically 12 
healthy obesity.  13 
Intrinsic and extrinsic factors modulate individuals‟ overfeeding response: intrinsic 14 
factors include genetic/ethnic background, baseline metabolic health and regional fat 15 
distribution; extrinsic factors include macronutrient (fat vs. carbohydrate) content, 16 
fat/carbohydrate composition and overfeeding pattern (larger portions vs. snacks). 17 
Subcutaneous adipose tissue (SAT) analysis, coupled with metabolic assessment, with 18 
overfeeding have revealed how SAT remodels to accommodate excess nutrients.  19 
Healthy remodeling involves adipocyte hyperplasia; dysfunctional remodeling 20 
involves hypertrophy inducing inflammation and insulin resistance. Biological 21 
responses of SAT also govern the extent of ectopic (visceral/liver) fat deposition. 22 
Body composition analysis by DEXA/MRI have determined the relative expansion of 23 
SAT (including abdominal/gluteofemoral SAT) versus ectopic fat with overfeeding.  24 
Such studies have contributed to the adipose expandability hypothesis whereby SAT 25 
 3 
has a finite capacity to expand (governed by intrinsic biological characteristics) and 1 
once capacity is exceeded ectopic fat deposition occurs. The potential for SAT 2 
expandability confers protection from/predisposes to the adverse metabolic responses 3 
to over-feeding. The concept of a personal fat threshold suggests a large inter-4 
individual variation in SAT capacity with ectopic fat/metabolic decompensation once 5 
one‟s own threshold is exceeded.  6 
This review summarises insight gained from overfeeding studies regarding 7 
susceptibility to obesity and related complications with nutrient excess.  8 
 9 
Introduction   10 
Long-term regulation and maintenance of body weight and body composition relies 11 
upon integrated systems controlling energy intake, energy expenditure, substrate 12 
utilisation and partitioning among different metabolic tissues and pathways. 13 
Peripheral signals released from the gastrointestinal tract and adipose tissue integrate 14 
within the hypothalamus to regulate energy intake and energy expenditure. Fat-free 15 
mass, through the resting metabolic rate, also regulates energy intake. It has been 16 
proposed that body weight is maintained at a „set-point‟ and that deviations from this 17 
point (with negative or positive energy balance) are countered and minimised by 18 
feedback mechanisms involving compensatory changes in appetite and energy 19 
expenditure
1, 2
.  20 
Obesity represents a state of energy imbalance created by mismatched energy 21 
expenditure (reduced physical activity) and energy intake (nutrient excess). However, 22 
individuals subjected to a similar relative positive energy balance show considerable 23 
heterogeneity in the extent to which their body weight or body composition is altered. 24 
Fat has the greatest storage capacity of the macronutrients; protein and carbohydrate 25 
 4 
have a much lesser capacity. Thus, body weight change occurs predominantly via 1 
alterations in adipose tissue volume with a much smaller contribution from changes in 2 
lean body mass. 3 
There is abundant information on weight loss (achieved in many different ways) but 4 
much less information on controlled weight gain. Overfeeding experiments, in which 5 
we mimic a short-term state of energy imbalance, have facilitated our understanding 6 
of the adaptive cellular, physiological and behavioral responses of adipose tissue and 7 
other organs (e.g. liver, skeletal muscle and brain) to weight gain and helped explain 8 
the inter-individual heterogeneity to weight gain. These studies have also provided 9 
insight into susceptibility to metabolic decompensation with weight gain.  10 
This is a narrative review, however, to ensure all relevant literature is considered, 11 
systematic searches were carried out on Medline and Scopus using the terms 12 
“overfeeding”, “overeating”, “hypercaloric”, “controlled weight gain” and 13 
“experimental weight gain” limited to English language papers with human subjects. 14 
2272 abstracts were screened, with 168 articles reporting the effects of hypercaloric 15 
diets in humans identified. This was supplemented by manual searches of reference 16 
lists. Reports from important overfeeding studies are described in this review, with 17 
data from experimental studies addressing the different baseline participant 18 
characteristics, overfeeding regimes imposed and imaging techniques (Table 1), 19 
effects on adipose tissue and ectopic fat distribution, adipocyte and metabolic 20 
responses (Table 2) and on adipokines, gut hormones and appetite regulation (Table 21 
3). 22 
 23 
Lessons learnt from early overfeeding studies  24 
 5 
Forty years ago, to understand the biological response of adipose tissue to weight gain 1 
(hyperplasia vs. hypertrophy), Sims et al conducted a landmark overfeeding study in 2 
inmates at Vermont State Prison
3
. He studied 5 lean individuals, with no family 3 
history of obesity, and in exchange for early parole subjected them to 10 weeks of 4 
supervised overfeeding while they remained sedentary. They were fed a diet of their 5 
own choice consisting of a three-fold higher caloric intake than would be needed to 6 
maintain body weight, aiming for 15-25% weight gain.  7 
Underlying the significant mean weight gain was a considerable inter-individual 8 
weight change between the inmates. The findings highlighted that the magnitude of 9 
weight gain cannot be predicted from the magnitude of positive calorie balance, with 10 
some individuals protected from, or predisposed to, weight gain through a variety of 11 
mechanisms. The key finding was that fat mass expansion occurred via an increase in 12 
adipocyte cell size rather than cell number i.e. adipocyte hypertrophy rather than 13 
hyperplasia occurred.   14 
 15 
Genetic basis for fat distribution and metabolic health 16 
Body fat distribution appears intrinsic to the individual and is likely to depend on 17 
heritable factors such as genetic variants, which are likely also subject to epigenetic 18 
regulation. A recent study identified 49 genetic loci associated with waist-to-hip ratio 19 
(adjusted for BMI), showing a stronger effect in women. These loci were enriched for 20 
genes expressed in adipose tissue with pathway analysis implicating adipogenesis, 21 
angiogenesis and insulin resistance as processes influencing fat distribution
4
. 22 
Several recent publications have highlighted several specific (common) genetic 23 
variants (particularly those associated with insulin resistance) where there is 24 
dissociation between the body mass index (BMI) and the risk of type 2 diabetes 25 
 6 
mellitus (T2DM) or cardiovascular disease (CVD) based on differing body 1 
composition/regional fat distribution
5, 6
. Genetic evidence has been provided for 2 
normal weight/lower BMI individuals with a metabolically obese phenotype, 3 
incorporating components of the metabolic syndrome and whose body composition is 4 
characterised by greater hepatic steatosis and increased visceral adipose tissue (VAT) 5 
relative to subcutaneous adipose tissue (SAT) (i.e. lower SAT capacity). These 6 
individuals were at an increased risk of T2DM, coronary artery disease or 7 
hypertension
5
. Conversely, genetic evidence has been provided for individuals with a 8 
higher BMI but lower risk of T2DM, hypertension and CVD. Presence of these 9 
„favourable adiposity alleles‟ are associated with lower insulin levels and a higher 10 
SAT:VAT ratio (i.e. higher SAT capacity) 
6
.  11 
The same genetic/epigenetic factors will also determine the pattern/distribution of fat 12 
depot expansion during weight gain.  13 
 14 
Conceptual framework for fate of excess energy (Figure 1) 15 
With overfeeding, there are two fates for the surplus energy: either through 16 
stimulation of energy expenditure or deposition in a storage depot (Figure 1A). 17 
However, the majority of excess energy is stored, rather than expended; the amount 18 
stored representing the difference between total energy expended and total energy 19 
ingested. The surplus energy maybe stored in adipose tissue (Figure 1B) or as lean 20 
body mass (Figure 1C). The biological properties of adipose tissue, and its response 21 
to overfeeding, profoundly influence the distribution of body fat change: upper vs. 22 
lower body fat and subcutaneous adipose tissue (SAT) vs. ectopic fat deposition 23 
including as visceral adipose tissue (VAT) or liver fat (Figure 1D). The distribution 24 
 7 
of excess body fat (whether stored as SAT, upper or lower body or as ectopic fat) has 1 
potentially profound secondary consequences on metabolic and cardiovascular risk.  2 
 3 
Changes in energy expenditure with overfeeding (Figure 1A) 4 
Total energy expenditure (TEE) is composed of resting energy expenditure (REE) 5 
(~60% of total), thermic effects of food and activity energy expenditure (exercise and 6 
non-exercise activity thermogenesis 
7
).  7 
TEE TEE is stimulated with overfeeding (by ~10%)
8
 but does not increase linearly 8 
with weight gain
9
. The extent of TEE stimulation during overfeeding governs the 9 
amount of excess energy stored and thus associated weight gain: individuals with a 10 
lesser tendency to gain weight increase TEE to a greater extent. With ensuing weight 11 
gain, resting metabolic rate will further increase (related to increased body mass) with 12 
recalibration dependent upon the relative changes in fat volume vs. muscle mass 13 
(skeletal muscle has higher relative energy requirements relative to adipose tissue)
10
. 14 
The stimulation of REE also depends upon the macronutrient content of the 15 
overfeeding regime with a hierarchy of macronutrient oxidation; macronutrients with 16 
limited storage capacity are oxidized first. Fat overfeeding has minimal effect on fat 17 
oxidation and total energy expenditure, such that 90-95% of excess energy is stored, 18 
resulting in greater fat accumulation. In response to carbohydrate overfeeding, there is 19 
stimulation of carbohydrate oxidation and an increase in TEE with a lower proportion 20 
(75-85%) of energy stored 
2
. Prolonged overfeeding carbohydrate increases body fat 21 
by stimulation of de novo lipogenesis of hepatic and extra-hepatic (adipose tissue) 22 
origin. The predominant effect of protein overfeeding is accretion of lean body mass 23 
with the effect of increasing resting metabolic rate
11
.  24 
 8 
Diet-induced thermogenesis (DIT) DIT, the energy expenditure associated with 1 
metabolising food, is also influenced by both the energy content and the 2 
macronutrient composition of the food ingested: isocaloric amounts of protein, 3 
carbohydrate and fat increase diet-induced energy expenditure by 20-30%, 5-10% and 4 
0-3% of TEE respectively. 5 
Activity energy expenditure (AEE) AEE is composed of energy expenditure related 6 
to spontaneous physical activity and non-exercise activity thermogenesis (NEAT). 7 
Differences in levels of NEAT have a greater impact on TEE than differences in 8 
spontaneous physical activity. Obese individuals tend to undertake less NEAT than 9 
lean individuals, being sedentary by a mean of 2 hours more per day
7
. NEAT has been 10 
shown to have a role in resistance to weight gain: individual susceptibility to 11 
overfeeding is determined by a variable induction in NEAT. 16 volunteers were 12 
overfed 1,000 calories daily for 2 months, with a mean weight gain of 10lb, but with a 13 
range of 2-16lb. Change in NEAT (kcal/day) was inversely correlated with fat gain 14 
(kg). Those with a high NEAT response were more protected from obesity with 15 
overfeeding; those with a low NEAT response were more susceptible to obesity with 16 
overfeeding
7
.  17 
 18 
Storage of excess energy (Figure 1B, C, D) 19 
Weight gain during overfeeding cannot be oversimplified by assuming 3,500 calories 20 
equates to a 1lb/0.45kg change in body weight, even if the energy surplus during 21 
overfeeding is accurately quantified. This erroneous assumption is based upon the 22 
premise that body weight changes reflect primarily loss or gain of adipose tissue 23 
(comprising 87% triglyceride), knowing the energy density of fat to be 9 kcal/g. 24 
Longer term changes in body fat are accompanied by changes in lean tissue whose 25 
 9 
metabolisable energy density is significantly less than body fat (4 kcal/g). Increased 1 
lean body mass would increase REE and higher body weight increases the energy 2 
requirement of physical activity. Mathematical models of energy expenditure and 3 
weight change have been developed that reflect the dynamic changes in body 4 
composition as weight increases
10
.  5 
A number of overfeeding studies have been performed with concomitant assessment 6 
of body composition by DEXA, CT and/or MRI to provide insight into which storage 7 
depot the excess energy is partitioned. Table 1 details the baseline participant 8 
characteristics and overfeeding regime used in overfeeding studies summarising those 9 
using concomitant assessment of body composition (DEXA  MRI) to determine fate 10 
of excess energy into regional fat depots, with results summarized in Table 2.  11 
Storage in adipose tissue vs. in lean body mass The concept of energy partitioning 12 
relates to the proportion of excess energy that is directed towards lean tissue vs. fat 13 
with the energy partition ratio being a non-linear function of body fat. People with a 14 
higher initial body fat have a greater fraction of their weight change attributable to 15 
increases in body fat vs. lean tissue
12
. 16 
Storage in upper body (abdominal) vs. lower body (gluteofemoral) fat. The regional 17 
distribution of SAT, quantified by DEXA, is critically important with subcutaneous 18 
fat depots in upper and lower body characterized by different structural and functional 19 
differences and therefore associated with different metabolic risk. Abdominal SAT 20 
(ASAT), i.e. upper body fat, is characterized by high uptake of diet-derived fat and a 21 
high lipid turnover.  In contrast, gluteofemoral fat (GFAT) has a reduced lipid 22 
turnover but a high capacity to accommodate fat undergoing redistribution 
13, 14
.  23 
Accumulation of adipose tissue in the upper body (abdominal obesity) is associated 24 
with increased risk of development of insulin resistance, type 2 diabetes mellitus and 25 
 10 
higher cardiovascular and total mortality, independent of BMI. Indeed, individuals 1 
with a normal BMI and abdominal obesity (determined by waist-hip ratio) have a 2 
higher mortality compared with either individuals with a normal BMI without central 3 
obesity or with all overweight or obese individuals (based on BMI)
15
. Conversely, 4 
accumulation of fat in the lower body (gluteofemoral obesity) shows opposite 5 
associations with cardiovascular disease and type 2 diabetes mellitus when adjusted 6 
for overall fat mass.  Paradoxically lower body fat accumulation is associated with 7 
improved cardiovascular and metabolic profiles (protective role) suggested to 8 
sequester lipids that would be destined for ectopic fat deposition
16
. 9 
Lower and upper body fat stores show a different response to weight gain reflecting 10 
their different biological characteristics and capacity for lipid storage/turnover
13
.  11 
Storage in subcutaneous adipose tissue vs. ectopic fat deposition (visceral adipose 12 
tissue and liver) Subcutaneous adipose tissue (SAT) must undergo expansion to 13 
accommodate increased lipid supply to avoid deposition of lipids/fatty acids in non-14 
adipocyte cells (causing lipotoxicity)
17
. SAT expansion may occur by two distinct 15 
mechanisms: hypertrophy of existing adipocytes or promotion of differentiation of 16 
pre-adipocytes (hyperplasia).   17 
The adipose tissue expandability hypothesis has suggested capacity for AT expansion 18 
is determined by functional adipocyte characteristics and their molecular and 19 
biochemical adaptive responses to positive energy balance
18
. This capacity is limited 20 
and determines the propensity for excess lipids to be orientated to other tissues i.e. 21 
ectopic lipid deposition, with secondary lipotoxicity. Taylor et al., proposed a large 22 
inter-individual variation in the SAT buffering capacity with each individual having a 23 
personal fat threshold
19
. This means that once the SAT storage capacity is reached, 24 
ectopic fat deposition ensues with associated lipotoxicity and metabolic dysfunction.  25 
 11 
These concepts of a finite AT expandability, which has large intra-individual 1 
variation, may explain the distinct body composition phenotypes of metabolic healthy 2 
and unhealthy, lean or obese
20
. Body composition analysis from these individuals 3 
have confirmed that metabolically unhealthy normal weight individuals are 4 
characterised by a low capacity for SAT expandability (low personal fat threshold) 5 
hence their higher lipid deposition in other organs (resulting in a higher VAT:SAT 6 
ratio and higher liver fat)
21
. Conversely, metabolically healthy obese individuals are 7 
characterised by a high capacity for SAT expandability (high personal fat threshold) 8 
(a lower VAT:SAT ratio and lower liver fat content)
20
.  9 
Insights from transgenic mice (lacking leptin while overexpressing adiponectin) 10 
demonstrate that massive expansion of SAT is metabolically inert, providing a safe 11 
harbor for potentially toxic lipids, with reduced ectopic fat (e.g. liver and visceral fat) 12 
and preserved insulin sensitivity with little/no systemic inflammation 
22
. In contrast, a 13 
reduced capacity for SAT expansion is associated with subsequent inflammatory 14 
consequences, development of systemic insulin resistance (IR) and metabolic 15 
syndrome (MS), associated with subsequent development of endothelial dysfunction 16 
and atherosclerosis. These findings are borne out by observations in people with 17 
generalised lipodystrophy, who have limited capacity for subcutaneous fat storage and 18 
consequently develop severe insulin resistance, NAFLD and dyslipidaemia
23
. 19 
Conversely, the PPARϒ agonists thiazolidinediones improve metabolic profiles by 20 
promoting adipogenesis and increasing fat mass
24
.  21 
 22 
Healthy and dysfunctional adipose tissue remodeling and metabolic 23 
consequences 24 
 12 
Healthy AT remodeling involves all cellular components of adipose tissue and not just 1 
adipocytes, with induction of various pathways within adipose tissue including that of 2 
lipid metabolism, the renin-angiotensin pathway, angiogenesis and extracellular 3 
matrix
25
. „Healthy‟ SAT expansion consists of hyperplasia, AT enlargement through 4 
recruitment of adipogenic precursor cells, stimulation of angiogenesis and remodeling 5 
of the extracellular matrix (ECM); „unhealthy‟ SAT expansion consists of adipocyte 6 
hypertrophy with limited angiogenesis and hypoxia resulting in secondary changes 7 
involving induction of tissue fibrosis
26
, adipocyte cell death and enhanced pro-8 
inflammatory cytokine secretion
27
. During this process there is a phenotypic switch 9 
with an infiltration of pro-inflammatory (M1) macrophages from the anti-10 
inflammatory (M2) phenotype
28
.  11 
A number of overfeeding studies have tested the validity of the adipose tissue 12 
expandability hypothesis by concomitantly examining changes in adipose tissue 13 
(morphology, gene and protein expression), body composition (using DEXA and/or 14 
MRI/
1
H-MRS) and the metabolic consequences (using oral glucose tolerance test or 15 
euglycaemic clamps) (summarised in Table 2). Thus we are able to simultaneously 16 
examine adaptations of the adipocytes structurally (e.g. adipocyte cell size, number 17 
and size distribution) and functionally (e.g. changes in expression of lipid metabolism 18 
genes) coupled with regional fat responses and partitioning of fat into different tissues 19 
(SAT vs. ectopic deposition). Such studies have provided mechanistic insight into 20 
how dysfunctional SAT remodeling contributes to visceral and liver fat deposition 21 
(clinically as non-alcoholic fatty liver disease, NAFLD) and in doing so initiating 22 
metabolic dysfunction with development of components of metabolic syndrome 23 
(dyslipidaemia, hypertension, insulin resistance).  24 
Alligier et al. overfed participants an additional daily lipid mixture composed of 70g 25 
 13 
(760 kcal) of saturated and monounsaturated fatty acids for 56 days
29
. Mean body 1 
weight change was 2.5 kg with substantial inter-individual heterogeneity in magnitude 2 
of weight gain and in the relative accretion of subcutaneous vs. visceral fat.  Although 3 
the increment in SAT was associated with the increase in body weight, there was no 4 
relationship between the increment in body weight and VAT nor was there any 5 
association between the expansion of SAT and VAT volumes. The magnitude of the 6 
increase in VAT volume was positively correlated with the magnitude of the post-7 
prandial exogenous fatty acid release in the circulation during a labelled palmitate test 8 
meal. Using SAT gene expression data, individuals with a high visceral fat gain 9 
appear to have reduced induction of expression of genes involved in triglyceride 10 
synthesis and lipid storage suggesting a reduced SAT lipid storage capacity in these 11 
individuals.  12 
Testing this hypothesis further Fabbrini et al. overfed obese individuals who were 13 
either metabolically healthy vs. unhealthy
30
. It was hypothesised that the 14 
metabolically healthy obese (MHO) will be resistant, whereas the metabolically 15 
abnormal (MAO), will be prone to the adverse metabolic effects of overfeeding. 16 
Employing stable isotopes, the results demonstrated that metabolically healthy obese, 17 
but not metabolically unhealthy obese, were protected from the adverse metabolic 18 
effects from weight gain with no change in hepatic and peripheral insulin sensitivity 19 
or in VLDL-TG secretion rates with overfeeding. This was related to upregulation of 20 
biological pathways and genes assoicated with AT lipogenesis in MHO, but not in 21 
MAO subjects. In contrast, McLaughlin et al, tested the hypothesis in obese, insulin-22 
sensitve (IS) vs. obese insulin-resistant (IR) individuals postulating similarly that the 23 
IS subjects would demonstrate an adapative adipose cell/tissue and metabolic 24 
response. To the contrary, they found that IS, but not IR, subjects had greater 25 
 14 
increases in VAT and liver fat and  had a greater metabolic decompensation with 1 
overfeeding
31
. This metabolic decompensation was correlated with smaller baseline 2 
adipocyte size, greater adipocyte enlargement and decreased expression of lipid 3 
metabolism genes. Previously it was thought that adipocyte enlargement occurred due 4 
to increased triglyceride storage but the simultaneously reduced expression of lipid 5 
metabolism genes as cells enlarge suggests this was not the case. Rather, as with the 6 
study by Johannsen et al.
32
, the influence of the baseline adipocyte cell size on 7 
worsening metabolic profiles suggest that adipocyte hypertrophy reflects impaired 8 
adipocyte differentiation faced with increased fat storage requirements. The 9 
explanation for these discrepant (and possibly counterintuitive) results are not clear, 10 
as the baseline characteristics of the two groups of study participants were not hugely 11 
dissimilar. 12 
Votruba et  al., also investigated whether baseline insulin sensitivity could predict the 13 
pattern of weight change, hypothesising that insulin resistant individuals would accrue 14 
more abdominal subcutaneous or visceral fat whereas insulin sensitive individuals 15 
would accrue leg fat. No relationship was found between baseline insulin sensitivity 16 
and the pattern of regional fat distribution in response to overfeeding
33
.  17 
 18 
Intrinsic factors influencing the response to overfeeding  19 
A number of studies highlight a significant genetic pre-disposition to the the relative 20 
amount and distribution of fat mass with overfeeding:   21 
Twin studies Several twin studies have provided strong evidence that genetic factors 22 
significantly contribute to the individual differences in the sensitivity to alterations in 23 
energy balance. In the Quebec feeding study 12 pairs of monozygotic twins were 24 
overfed by 1000 kcal, six days a week for 84 days with a mean weight gain of 8.1kg 25 
 15 
(2.7kg lean body mass). Although the range of weight gain between the twin pairs 1 
was staggering (4.3-13.3kg) with no correlation between the total energy ingested and 2 
weight gained, there was a high degree of concordance within each twin pair between 3 
the amount of weight gained and the distribution of excess energy
34
.  4 
Family history of type 2 diabetes mellitus (T2DM) Healthy individuals with a family 5 
history of T2DM are predisposed to the adverse effects of overfeeding. The response 6 
to overfeeding was studied in 41 sedentary individuals with and without a family 7 
history of T2DM (FH+ and FH- respectively). FH+ individuals gained more weight 8 
and became more insulin resistant
35
.  9 
Ethnicity It is well established that South Asians are more susceptible to central 10 
obesity and cardiometabolic consequences
36
. This maybe explained by their 11 
phenotype of higher fat mass and lower lean mass, contributing to insulin resistance
37, 12 
38
. Overfeeding experiments with a short-term, high fat diet in South Asians vs. 13 
Caucasians has shown a more detrimental effect on the metabolic profile
39, 40
. 14 
Effect of low birth weight Individuals with a low birth weight, despite their 15 
increased risk of insulin resistance when exposed to a high fat diet, did not differ 16 
in their AT response compared with control subjects
41
.  17 
Participant characteristics Inter-individual differences in baseline characteristics 18 
explain varying weight change with factors such as low basal metabolic rate, lower 19 
baseline lipid oxidation (higher respiratory quotient, RQ), lower levels of spontaneous 20 
physical activity predisposing individuals to greater weight gain
42
. Baseline body 21 
weight and amount of body fat also determine the magnitude of the weight change 22 
and even for the same increment in energy intake these differ in lean and obese 23 
people.  24 
 25 
 16 
Extrinsic factors influencing the response to overfeeding  1 
Overfeeding regime characteristics The duration, energy density and the 2 
macronutrient composition of the overfeeding regime influences the response to 3 
overfeeding.  4 
Effects of macronutrients A key consideration is the macronutrient composition of 5 
overfeeding and whether the effects differ depending on whether excess calories arise 6 
from high-fat, high-carbohydrate or a combination of both. This is particularly 7 
pertinent with conflicting public health messages about the relative merits and perils 8 
of high-fat or high-carbohydrate diets. Surprisingly, few studies have compared 9 
overfeeding regimens based on these macronutrients. Two studies characterised the 10 
effects of overfeeding with high fat vs. high carbohydrate diet on energy storage. Both 11 
showed comparable weight gain, however, Horton et al showed dietary fat to lead to 12 
greater fat accumulation than carbohydrate, whereas Lammert et al found there was 13 
no difference in fat storage based on macronutrient, explained by carbohydrates 14 
inducing hepatic and extrahepatic lipogenesis
2, 43
. Two small, short term studies have 15 
found fat and carbohydrate overfeeding to have similar effects on liver fat, however 16 
comprehensive assessment including molecular biology techniques and metabolic 17 
end-points is lacking 18 
 
44, 45
. Bray et al. recently compared overfeeding regimes with different levels of 19 
dietary protein, finding the low protein group showed a greater increase in % body fat, 20 
but a decrease in intrahepatic lipid
46
. 21 
Influence of dietary fat composition In the LIPOGAIN study Rosqvist et al., overfed 22 
healthy individuals muffins with either polyunsaturated fatty acids (PUFA) or 23 
saturated fatty acids (SFA) and demonstrated distinct effects on the magnitude and 24 
distribution of fat deposition and on lean tissue
47
.  With the PUFA diet equal amounts 25 
 17 
of fat and lean tissue were added; in contrast, with a SFA diet four times as much fat 1 
as lean tissue was added.  2 
Influence of dietary carbohydrate composition There has been interest in comparing 3 
the effects of different sugars on metabolic health, especially given a proposed link of 4 
excess fructose consumption with non-alcoholic fatty liver disease
48
. A small number 5 
of studies have compared fructose and glucose overfeeding. Two meta-analyses called 6 
for more data but found no difference in either lipid profile or ectopic fat deposits 7 
between different carbohydrate sources 
49, 50
. 8 
Influence of pattern of feeding The effects of overfeeding differ according to the 9 
frequency and timing of the food intake. Overeating by consuming frequent meals 10 
(i.e. snacking) rather than isocaloric, large meals differentially affects the 11 
accumulation of intra-abdominal and liver fat 
51
.  12 
 13 
Effects of overfeeding on other tissues/organs.  14 
Skeletal muscle Effects in skeletal muscle have been examined and as in adipose 15 
tissue there is evidence of induction of extracellular matrix remodeling, inflammation, 16 
reduced insulin signaling and insulin resistance
27, 52
 . 17 
Cardiovascular system Increasing BMI is clearly linked with increasing risk of 18 
CVD
53
 although individuals with metabolically healthy obesity may have some 19 
protection against it
54
. Similarly, normal weight individuals who are metabolically 20 
unhealthy (MUNW) also maybe at increased CV risk
15
. Cross-sectional mechanistic 21 
data involving detailed body composition and echocardiography shows that 22 
subclinical measures of systolic and diastolic myocardial performance are related to 23 
fat distribution and metabolic health rather than simply fat mass
21
. Metabolically 24 
healthy individuals, whether lean or obese, with lower VAT and liver fat have 25 
 18 
preserved myocardial function compared with lean or obese, metabolically unhealthy 1 
individuals
21
.  2 
 3 
Effects of overfeeding on appetite and gut hormone regulation 4 
Consistent with the concept of a weight „set point‟, it has been speculated that a 5 
period of overfeeding may be accompanied by subsequent compensatory changes in 6 
peripheral signals from the gut or expanded adipose tissue mass that would help 7 
normalise body weight. Despite this there are few studies that have characterised 8 
alterations in the circulating levels of gut hormones or adipokines in response to 9 
overfeeding, nor to the modulation of appetite. The design, participants and results of 10 
these studies are summarized in Table 3. 11 
Cornier et al., examined activation of key brain regions in response to visual food 12 
cues (control images, neutral hedonic value and high hedonic value food items) using 13 
functional MRI (fMRI). They studied participants after two days of eucaloric energy 14 
intake, followed by two days of overfeeding with 30% excess energy intake 15 
consumed. There was significant attenuation of the effect of the high hedonic value 16 
images after two days of overfeeding. Satiety ratings were also higher and hunger 17 
ratings lower after the overfeeding
55
. When comparing thin and reduced-obese 18 
individuals, the attenuation of the activation of brain regions by high hedonic value 19 
images after overfeeding was not observed in the reduced-obese individuals 20 
suggesting a propensity to gain weight
56
. Gut hormone responses have also been 21 
examined with conflicting results (Table 3).  22 
 23 
Interaction of overfeeding with changes in physical activity  24 
 19 
Few studies have examined the interaction of changes in physical activity with 1 
overfeeding. Knudsen et al., implemented a 14 day overfeeding protocol (total energy 2 
intake increased by ~50%) combined with physical inactivity (step reduction to 1,500 3 
steps/day) in healthy young men
57
. Changes in insulin sensitivity were apparent prior 4 
to changes in body composition measured by DEXA/MRI
57
. Wahlin implemented a 5 
similar protocol for 7 days, with an overconsumption of 50% excess energy 6 
simultaneously restricting the physical activity to below 4,000 steps, and similarly 7 
noted a dramatic reduction in insulin sensitivity with modulation of key metabolic 8 
genes (e.g. SREBP1c and FAS) and protein expression (GLUT4, AMPK, AKT1 and 9 
AKT2) within adipose tissue
58
. Significantly, the same short-term overfeeding and 10 
reduced physical activity protocol, with inclusion of 45 min of daily treadmill running 11 
at 70% maximal oxygen uptake, counteracted most of the detrimental effects at a 12 
whole-body and adipose tissue level, despite the provision of additional dietary 13 
energy intake to account for the extra energy expended by exercise
58
.  14 
 15 
Conclusions and future lines of research 16 
The challenge with the current obesity epidemic is to understand how to facilitate 17 
healthy AT remodeling expansion with hyperplasia, involving adipocyte 18 
differentiation, rather than dysfunctional AT remodeling with hypertrophy, induction 19 
of insulin resistance and inflammation. In doing so we can reduce ectopic fat and 20 
potentially ectopic fat-related complications, T2DM, NAFLD and CVD. Prediction of 21 
personal fat thresholds would help individuals maintain their metabolic health as long 22 
as possible. Overfeeding studies using drugs that cause SAT proliferation (e.g. 23 
thiazolidinediones) to facilitate healthy AT expansion and partition excess lipid in the 24 
SAT may provide useful insight. This review has highlighted the paucity of 25 
knowledge regarding adipose tissue, metabolic and cardiovascular responses to excess 26 
 20 
calories from fat vs. carbohydrate intake. This area is a major concern for public 1 
health and appropriate dietary recommendations and is a knowledge void that needs 2 
filling. 3 
 4 
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Figure legends 1 
 2 
Table 1 Overview of feeding studies detailing baseline participant characteristics and 3 
overfeeding regime summarising those using concomitant assessment of body 4 
composition (DEXA  MRI ±CT) to determine fate of excess energy into regional fat 5 
depots. F Fat; CHO Carbohydrate; NAFLD Non-Alcoholic Fatty Liver Disease. 6 
 7 
Table 2 Key studies examining adipose tissue deposition, changes in adipose tissue 8 
structure/biology and metabolic consequences following overfeeding. IHTG 9 
Intrahepatic triglycerides; TG Triglycerides; HOMA-IR Homeostatic Model 10 
Assessment- Insulin Resistance; NEFA Non-esterified Fatty Acids; SAT 11 
Subcutaneous Adipose Tissue; AUC Area Under Curve; FFA Free Fatty Acids; 12 
VLDL Very Low Density Lipoproteins; IMCL Intramyocellular Lipids; IS Insulin 13 
Sensitivity 14 
 15 
Table 3 Key studies examining changes in appetite or circulating levels of 16 
adipokines/gut hormones in response to overfeeding. CHO Carbohydrate; F Fat; P 17 
Protein; VAS Visual Analogue Scales; fMRI functional Magnetic Resonance 18 
Imaging; PYY Peptide YY; GLP-1 Glucagon-like peptide-1. 19 
 20 
Figure 1 Conceptual framework highlighting potential mechanisms where inter-21 
individual differences in partitioning of excess energy with overfeeding may arise. 22 
Inter-individual differences may arise due to A) proportion of excess energy expended 23 
vs. excess energy stored, B) relative storage in adipose tissue vs. in lean body mass, 24 
C) relative storage in upper body vs. lower body fat, D) amount of ectopic fat 25 
 34 
deposition in visceral adipose tissue (VAT), liver or other organs (skeletal muscle, 1 
heart or pancreas etc.). 2 
 3 
Figure 2 The relationship between BMI and insulin sensitivity is not linear as 4 
suggested by epidemiological evidence. Rather individuals are susceptible to 5 
metabolic decompensation when their weight exceeds their „personal fat threshold‟. 6 
This threshold varies hugely: those with a low „personal fat threshold‟ are more 7 
susceptible to cardio-metabolic decompensation with only modest weight gain 8 
(metabolically unhealthy normal weight) vs. a higher threshold means individuals can 9 
withstand much greater weight gain without decompensating (metabolically healthy 10 
obese) (adapted from Taylor et al.
19
). 11 
 35 
 36 
 37 
 1 
Table 1
DEXA 
CT at L2/3, L3/4 and L4/5.
17 non-diabetic males (n=5), 
females (n=11)
Abdominal MRI (T1-
weighted)
(56% with NAFLD) Liver 1H-MRS
NR DEXA 
(range 18-30) Abdominal MRI 
(T1-weighted)
36 healthy men, 4 groups:  140% BL requirement: 
increased meal size (S) or 
frequency (F).
  HFHS-S n=8 22.6±2.9 22.3±1 Two supplements:
  HFHS-F n=8 21.5±1.9 22.5±1.5   High Fat High Sugar (HFHS): 
  HS-S n=10 22±2.5 21.7±1.1 49% CHO, 35% F, 16% P
 HS-F n=10 21.9±2.8 22.6±1.8   High Sugar (HS):
 Commercial sucrose drinks. 
Abdominal MRI (T1-
weighted) 
39 healthy subjects: Abdominal MRI 
  PUFA intervention: 5 women, 13 
men
PUFA: 
26.7±4.6
PUFA: 20.8 
(19.5-23.1)
1H-MRS liver 
20 obese subjects: Abdominal MRI (T1-
weighted) 
  Metabolically normal (MNO; 
IHTG <5.6%) n=12   
MNO: 43±10 MNO: 
34.0±3.0
Liver 1H-MRS
  Metabolically abnormal (MAO; 
IHTG >10%) n=8
MAO: 52±7 MAO: 
35.7±3.9
15 insulin-sensitive 54 ±8 29.3±2.4 Regular diet+ snacks/beverages CT measured SAT, VAT and 
mid-thigh fat
16 insulin resistant 57±6 30.7±2.7 Mean additional calories 880 
kcal/d (50% CHO, 35% fat, 
15% protein)
Liver 1H-MRS
Target weight gain 3.2 kg 
(0.8kg/week)
Period
1H-MRS of liver and soleus 
muscle 
  SFA intervention: 6 women, 13 
men
SFA: 
27.1±3.6
SFA: 19.9 
(18.9-20.7)
Pancreatic MRS
44 healthy men
Body composition analysis 
modality
Van der Meer et 
al.  200859
15 healthy men 25±6.6 23.4±2.5 Normal diet + 2632 kcal/d; 94% 
F
3 days Free living Cardiac and liver 1H-MRS 
Reference Baseline characteristics Mean Age 
(y)
Mean BMI 
(kg/m2)
Overfeeding regime Activity
DEXA/Abdominal MRI
Usual
Free living
Sevastianova et al. 
201260
Median 54 
(40-59)
30.6±1.2 Normal diet + 1000kcal/d; 98% 
CHO
21 days Free living
Tchoukalova et al. 
201013  and 
Votruba et al. 30
28 healthy men (n=15), women 
(n=13)
NR 22.1±0.5 Tailored to achieve 5% weight 
gain
56 days
Alligier et al. 
2012,201325, 29
14 days
33±1 Regular diet + 760kcal/d; 91% F 56 days
Step reduction 
<1500 steps/day 
(10278±2399 to 
1521±488)
Knudsen et al. 
201257
9 healthy men 24±3.3 21.6-±2.5 Usual diet + 1500kcal as snack 
packages
Abdominal MRI (T1-
weighted) Liver 1H-MRS
56 days Free living
Rosqvist et al . 
201447
Regular diet + muffins (51% F, 
5% P, 44% CHO) titrate to 
weight gain supplemented with 
polyunsaturated  (PUFA) or 
saturated (SFA) fat  
49 days Usual
Johannsen et al. 
201432
29 healthy men 26.8±5.4 25.5±2.3 1.4X BL energy requirement; 
41% CHO, 44% F, 15% P.
Koopman et al. 
201451
42 days Free living
Liver 1H-MRS
McLaughlin et al 
201631
28 days Free living
Fabbrini et al. 
201530
Regular diet +1000kcal/d 
maintaining macronutrient 
intake. Delivered via specific 
menu choices from fast food 
chains.
Until 5-7% 
weight 
gain; mean 
52 days
Free living
Boon et al . 201561 24 healthy men 22.1±0.4 21.5±0.4 Regular diet +1275kcal/d; 94% 
F
5 days No physical 
activity
Table 2
Changes in SAT Changes in VAT Changes in liver fat Insulin Sensitivity Lipid levels
IHTG: 2.01±1.79% to 
4.26±2.78%
TG 1.3±0.4 to 
2.9±1.1mmol/L
Cardiac TG: 
0.38±0.18% to 
0.4±0.12%)
NEFA 0.54±0.29 to 
0.92±0.33mmol/L
Upper body: Femoral/abdo SAT 
+22.0±2.6% (women) Size (µg lipid/cell):
+41.0±7.3% (men) Abdo: +39±11%
Lower body: Femoral: ±12±8%
+18.2±1.3% (women) No. (x109):
+34.9±5% (men) Upper body: +3±5%
Lower body: +23±7%
1.8±0.3kg TG 1.1±0.11 to 
1.4±0.12; 
(88.7±4.1 to 
90.5±4.1kg)
FFA 424±31 to 
416±38
Lipogenic index 
16:0/18:2n-6 ratio:
TG 2.1 (1.9-2.3) to 
2.6 (2.4-4.1)
VLDL 2.1±-0.3 to 
3.2±0.5
2.5kg Abdominal SAT 
79.1±1.8 to 
81.6±1.8kg
Size (cell surface 
µm2) 3123±129 to 
3120±160
Number (cells/mm2) 
320±16 to 336-±28
1.6kg HOMA-IR 1.1 to 1.6 TG 0.92 (0.64-1.3) 
to 1.13 (0.89-1.43) 
mM
71.3±3.5 to 
72.9±3.4kg
OGTT AUC 
increased 37±10%
FFA 362.5(267.5-
491.2) to 233.4 
(138.5-393.1) µM
Clamp: glucose 
infusion rate reduced 
by 43.6±11%.
Matsuda index 
reduced by 26±14%
POOLED 
HFHS/HS-S:
POOLED HFHS/HS-S: Pooled HFHS/HS-S:
BMI 22.05±0.98 
to 22.75±1.04
0.225±0.06 to 
0.228-±0.056L
0.196±0.068 to 
0.215±0.041L
IHTG: 0.83±0.38 to 
1.00±0.78%
POOLED 
HFHS/HS-F:
POOLED HFHS/HS-F: Pooled HFHS/HS-F:
BMI 22.5±1.5 to 
23.2±1.6
0.276±0.111 to 
0.315±0.115L
0.239±0.073 to 
0.266±0.077L
IHTG: 1.22±0.93 to 
2.18±1.9%
+7.6±2.1kg IHTG: 1.5±0.6 to 
2.19±1%
Clamp (glucose 
infusion rate):
(81.9±10.3 to 
89.5±-9.4kg)
IMCL: 0.45±0.24% to 
0.49±0.24%
Low dose insulin: 
+18%
High dose insulin: 
+5%
EGP suppression: 
96±10% to 82±20%
PUFA 
1.6±0.85kg (BL 
67.4kg)
Abdominal SAT: 
PUFA +0.25±0.32L 
(baseline: 2.2L)
PUFA +0.11±0.21L 
(baseline 0.99L)
IHTG: PUFA 
+0.04±0.24% (baseline 
0.75%)
HOMA-IR: PUFA 
+0.2±-0.5 (baseline 
1.23)
SFA 1.6±0.96kg 
(BL 63.3kg)
SFA +0.34±0.23L 
(baseline: 1.8L)
SFA +0.22±0.16L 
(baseline: 0.81L)
SFA +0.56±1% 
(baseline 0.96%)
SFA +0.18±0.3 
(baseline 1.04)
Hypercaloric diet with 
increased meal 
frequency increased 
intrahepatic fat 
independent of body 
weight gain and 
caloric content. 
Smaller adipocyte size 
associated with a 
greater decrease in 
insulin sensitivity. No 
association between 
adipocyte size and 
ectopic fat
NA
Changes in IHTG and 
VAT associated with 
changes in palmitic 
acid (SFA). Linoleic 
acid (PUFA) inversely 
associated with liver 
fat. 
Rosqvist et al 
201447
NA NA
Johannsen et al 
201432
Abdominal SAT: 
+1.3kg (4.1±1.5 to 
5.4±1.8kg)
Abdominal VAT: 
+0.36kg (0.58±0.49 
to 0.94±0.58kg)
TG (mg/dL) 87±42 
to 96±68
Knudsen et al 
201257
NA 28.8±13.5 to 
43.1±20.5cm3
NA NA
Koopman et al 
201451
NA Clamp: no change in 
peripheral insulin 
sensitivity.
TG significantly 
increased in HFHS-F 
group only 
(0.56±0.21 to 
0.84±0.32mmol/L)
Reduction in insulin 
sensitivity precedes 
changes in body 
composition.
Increase in liver fat 
proportionate to de 
novo lipogenesis
Alligier et al 
2012,201325, 29
91±7 to 100±7cm3 92±11 to 
102±11cm3
NA HOMA-IR 2.29±0.16 
to 2.44±0.15
FFA (µM) 418±23 
to 355±16
NA
Sevastianova et 
al.,  201260
4440 (3700-6210) to 
4570 (4000-6280)cm3
2180±300 to 
2290±310cm3
IHTG: 9.2±1.9% to 
11.7±1.9%
NA HOMA-IR 1.7±0.3 to 
1.8-±0.2
BMI increased 
23.4±2.5 to 
23.6±2.5
NR NR NA HOMA 2.0±1.2 to 
4.9±2.3
Key findingsReference Weight gain 
(kg)
Changes in fat distribution Adipocyte response Metabolic response
NA
Tchoukolava et al 
201013 and 
Votruba et al. 30
4.6±2.2kg +40.5%±5.8 NA 24 Insulin AUC 
Increased by 
2685±6252 (p=0.04). 
NA Abdominal SAT 
adipocyte size 
correlated with upper-
body fat gain. No 
correlation between 
between baseline 
insulin sensitivity and 
upper body SAT or 
VAT gain.
Van der Meer et 
al. 200859
MNO: +6%; 
95.8±13.7 to 
101.7±14.4kg
MNO: +2%; (3008±796 
to 3071±809cm)
MNO: +12%; 
885±240 to 
987±295cm3
IHTG MNO: 2.4±1.1 to 
3.9±2.6%
HOMA-IR: MNO: 
+10% (baseline 2)
TG (mg/dl): MNO: 
0% (89±43 to 
89±32)
MAO: +6%; 
103±11 to 
109±11.6kg
MAO: +5%; 3145±871 
to 3308±928cm3
MAO: +12%; 
1714±585 to 
1912±645cm3
MAO: 15.2±4 to 
22.8±4.3%
MAO: +22% 
(baseline 6)
MAO +27% 
(134±61 to 170±52)
TG (mmol/l): 
1.0±0.1 to 1.0±0.1
IS 86.2±10.1 to 
89.6 ±10.3
IS: 147 ± 54 to 162 ± 
51cm3
IS: 37±22 to 
44±28cm3
IHTG: IS: 0.03 ± 0.21 
to 0.07 ± 0.04
Abdominal SAT size 
and structure:
IR 89.4±11.2 to 
92.1±11.1
IR: 140 ± 34 to 148 ± 
37cm3
IR: 64±16 to 
73±27cm3
IHTG: IR: 0.23±0.31 
to 0.3±0.22
Peak adipocyte 
diameter increased 
significantly only in IS 
subgroup.
 
NA
Smaller adipocyte size 
associated with a 
greater decrease in 
insulin sensitivity. IS 
rather than IR subjects 
experienced metabolic 
decompensation than 
IS subjects.
Significant decrease in 
percentage of small 
adipose cells in IS 
Clamp: Suppression 
of glucose rate of 
appearance lower in 
MAO group. 
VLDL apoB100: 
secretion increased 
in MAO but not 
MNO (p=0.004)
NA HOMA-IR: 
1.62±0.26 to 
2.39±0.32
NANA IHTG: 1.57±0.27% to 
3.43±0.49%
McLaughlin et al 
201631
Muscle insulin 
resistance worsened 
in IS group only: 
45%(IS) vs.  8%(IR) 
Insulin suppression 
of lipolysis 
worsened 
significantly in the 
IS subgroup alone 
NAFabbrini et al 
201530
Transcriptional 
pathways related to 
lipid metabolism and 
synthesis: upregulated 
in metabolically 
healthy but not in 
metabolically 
unhealthy 
Boon et al 201561 69.1±1.9 to 
69.6±1.9kg
NEFA (mmol/l) 
0.5±0.03 to 0.5±0.03
Table 3
Reference Baseline 
characteristics
Mean Age 
(y)
Mean BMI 
(kg/m2)
Dietary protocol Period Activity Changes in appetite Changes in gut hormones
13 thin (7 women, 6 
men) and 9 reduced 
obese (RO; 5 women, 4 
men) subjects. 
Thin: 30.6±8 
(women) 
29.3±7.6 
(men).
Thin: 
20.6±1.8 
(women) 
21.3±3 (men).
VAS: pre-meal hunger reduced 
in thin but not RO group 
following OF. Post meal satiety 
increased in thin but not RO 
group following OF.
fMRI response to visual food 
cues (high hedonic 
value>neutral hedonic value) 
blunted by overfeeding.
Ad libitum intake higher on 
first day following OF compared 
with others. Trend towards lower 
than baseline ad libitum intake 
following OF (significant only in 
HF/LED group).
2 days 
eucaloric 
intake, 2 days 
overfeeding
Habitual 
physical 
activity
VAS: decreased hunger and 
increased satiety following 
HF/LED overfeeding only.
Physical 
activity 
tailored so 
energy 
expenditure 
stable over 
study period.
N/A3 arm cross 
over design: 2 
days OF with 4 
days 
measurement 
of ad libitum 
intake
Fasting GLP-1 increased in 
all groups with no difference 
based on weight status
4 weeks Habitual 
physical 
activity
N/A Incremental AUC for PYY 
and GLP-1 unchanged in 
CT group and decreased in 
normal weight group after 
overfeeding. Fasting ghrelin 
increased after overfeeding, 
lower in CT group vs 
normal weight.
N/A Fasting serum acylated 
ghrelin increased in all 
groups in response to 
overfeeding
1 week Not reported N/A
Apolzan et al 
201468
15 men and 5 women. 1 
normal weight, 8 
overweight, 11 obese, 
otherwise healthy
34±9 30.7±4.6 140% energy requirements. 
3 diets: High fat/low 
energy density (HF/LED; 
1.05kcal/g; 50% F, 35% 
CHO, 15% P) , high 
fat/high energy density 
(HF/HED; 1.6kcal/g; 50% 
F, 35% CHO, 15% P), high 
carbohydrate/low energy 
density (HC/LED; 
1.05kcal/g; 20% F, 65% 
CHO, 15% P)
Germain et al., 
201467. 
8 constitutionally thin 
(CT) women (BMI 
<17.5 with no eating 
disorder or nutritional 
deficiency) and 8 
normal weight controls
21.6±1.9 vs 
22.1±0.8
17.1±0.3 vs 
22.1±0.3
630kcal excess from fat 
(peanuts, cheese, olive oil, 
butter).
Wadden et al., 
201366
72 healthy young men 
(normal weight n=30; 
overweight n=14; obese 
n=28)
23.11 ±0.37 25.27-±0.56 70% more calories than 
required (15% protein, 35% 
fat and 50% carbohydrate
Not reported N/A Serum PYY concentration 
significantly increased in 
response to overfeeding
Wadden et al ., 
201265
68 young men (normal 
weight, n=26; 
overweight, n=14; 
obese, n=28)
23 ± 0.4y 25.6 ± 0.6 70% more calories than 
required (15% protein, 35% 
fat and 50% carbohydrate
1 week Not reported
Cahill et al., 201164 69 young men 70% more calories than 
required (15% protein, 35% 
fat and 50% carbohydrate
1 week 
Leptin elevated (+116%)
Cornier et al , 
200755
25 healthy men (n=12), 
women (n=13)
35.6 ± 6.2y 
vs. 33.8 ±4.7y
Habitual 
physical 
activity
N/A2 days eucaloric energy 
intake followed by 2 days 
overfeeding with 30% 
above eucaloric needs 
VAS: reduced hunger and 
increased satiety ratings.
Jebb et al,  200663 6 non-obese men 43.3 ± 10.6 21.9 ± 1.3 Overfeeding periods 
(+20%, +40%, +60% 
energy intake with fat) 
followed by free diet 
periods
3 x 3weeks Food intake stimulated overall 
during free diet period. Variable 
change with ‘compensators’ and 
‘non-compensators’.
21.0 ± 1.3 vs. 
22 ± 1.9
Cornier et al, 
200462
Eucaloric diet for 7 days 
followed by 50% 
overfeeding (50% CHO, 
30% F, 20% P).
7 days 
eucaloric 
intake, 3 days 
overfeeding
Habitual 
physical 
activity
N/A
RO: 38.2±8.3 
(women), 
36.5±7.05 
(men)
RO group underwent 
period of 10% weight 
loss then 4 weeks 
weight stability before 
study
Ad libitum energy intake: 
following OF non-significantly 
reduced in all.
RO: 30.4±2.6 
(women), 
27.5±1.8 
(men)


